Opdyta 40mg Injection
Marketer
BMS India Pvt Ltd
Salt Composition
Nivolumab (40mg)
Overview Opdyta 40mg Injection
Pembrolizumab 40mg injection treats various cancers including non-small cell lung, kidney, head and neck, melanoma, Hodgkin's lymphoma, and liver cancer. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your specific condition and may vary. Strictly adhere to your doctor's prescribed regimen; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects may take weeks or months to manifest; discontinue only under medical guidance. Common side effects include skin rash, fatigue, headache, and pyrexia. Infusion-related serious adverse events can comprise chills, shivering, pruritus, erythema, flushing, dyspnea, and vertigo, necessitating post-infusion monitoring for allergic reactions. Prior to treatment, inform your physician of any pre-existing lung, liver, or kidney conditions, or concomitant use of anti-infectives. Drug interactions are possible; disclose all medications to your healthcare provider. This medication is contraindicated in pregnancy and lactation; effective contraception for both partners is crucial during therapy.
Primary Ingredients of Opdyta 40mg Injection
No information provided. Please provide the text you wish to be rewritten.
Uses of Opdyta 40mg Injection
Lung cancer (excluding small cell type)|Renal cell carcinoma|Cancers of the head and neck|Cutaneous melanoma|Lymphoma (Hodgkin's)|Hepatocellular carcinoma
Major Benefits of Opdyta 40mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Opdyta 40mg Injection:
- Rash
- Weakness
- Headache
- Fever
- Musculoskeletal (bone, muscle or joint) pain
- Back pain
- Stomach pain
- Nausea
- Itching
- Constipation
- Diarrhea
- Upper respiratory tract infection
- Decreased appetite
- Breathlessness
- Cough
How to use Opdyta 40mg Injection:
Administering this medication will be handled by your physician or their qualified staff. Self-medication is strongly discouraged.
How Opdyta 40mg Injection works:
Opdyta 40mg Injection, an anticancer agent, inhibits the PD-1 protein found on T lymphocytes, thereby unleashing their cancer-killing potential.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Opdyta 40mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Opdyta 40mg Injection to pregnant individuals is contraindicated due to confirmed harm to the fetus. In exceptional, life-threatening circumstances, a physician might consider its use if the potential advantages outweigh the inherent dangers. Physician consultation is mandatory.
Breast feedingCONSULT YOUR DOCTOR
The administration of Opdyta 40mg Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by a 40mg Opdyta injection.
KidneySAFE IF PRESCRIBED
Opdyta 40mg Injection poses no safety concerns for patients with renal impairment; no dosage modification is necessary.
LiverSAFE IF PRESCRIBED
Opdyta 40mg Injection can be administered to patients with hepatic impairment without requiring a change in dosage.
What if you forget to take Opdyta 40mg Injection :
NA
Facts to Know About Opdyta 40mg Injection
| Label | Value |
|---|---|
| Chemical Category | Monoclonal antibody |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | PD-1 Checkpoint Blockade Therapy |
3,018 People bought this recently